Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2026)

Pulse Biosciences' Cost of Revenue history runs 3 years deep, the most recent figure standing at $279000.0 for Q3 2025.

• In Q3 2025, Cost of Revenue changed N/A year-over-year to $279000.0; the TTM figure through Sep 2025 stood at $279000.0 (changed N/A YoY), while the FY2022 annual figure was $11.9 million, up 506.91% from the prior year.
• Cost of Revenue for Q3 2025 stood at $279000.0, down from $1.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $8.4 million in Q3 2022, with the low at $279000.0 in Q3 2025.
• The 3-year median for Cost of Revenue is $1.2 million (2021), against an average of $2.0 million.
• Peak annual rise in Cost of Revenue reached 1055.43% in 2022, while the deepest fall reached 4.03% in 2022.
• Pulse Biosciences' Cost of Revenue stood at $1.2 million in 2021, then gained by 4.03% to $1.3 million in 2022, then sank by 78.39% to $279000.0 in 2025.
• Business Quant data shows PLSE's Cost of Revenue at $279000.0 in Q3 2025, $1.3 million in Q4 2022, and $8.4 million in Q3 2022.